GUFICBIO.NS

Gufic Biosciences Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$371.25

Jun 12, 2026

Market cap

$37.28B

52w range

—

P / E

—

EPS · FY 2026

$6.40

Volume

—

Revenue · FY 2026

$9.44B

Explain this page

Arphra AIPlain-English read on Gufic Biosciences Limited’s valuation

Revenue · 5Y

$9.44B

FY26

Net income · 5Y

$642.1M

FY26

Margins · FY2026

Gross margin36.0%

Operating margin12.8%

Net margin6.8%

FCF margin-1.9%

income_statement_annual

Pro

Full income statement, balance sheet, and cash-flow history is included with Pro.